<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Chemotherapeutic Agents: Antiparasitics</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="pharmacology-chemotherapeutic-agents-antimycobacterials-antifungals-antivirals.html" class="nav-button">
                        <span class="nav-icon">‚Üê</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 36%;"></div> <!-- Set percentage dynamically -->
                        </div>
                       <span class="progress-text">Lecture 4 of 11</span> <!-- Update text -->
                    </div>
                    <a href="pharmacology-cancer-chemotherapy.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">‚Üí</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">Chemotherapeutic Agents: Antiparasitics</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">

                <!-- START: trypanosomiasis-treatment -->
                <section id="trypanosomiasis-treatment" class="content-section" aria-labelledby="section-heading-trypanosomiasis">
                    <h2 id="section-heading-trypanosomiasis" class="section-heading">
                         <span class="heading-icon">ü¶ü</span>
                        <span class="heading-text">Treatment of Trypanosomiasis</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">1. SURAMIN</h3>
                        <p><strong>Adm:</strong> parenteral</p>
                        <p><strong>Distribution</strong> - does NOT enter CNS</p>
                        <p><strong>Elimination:</strong> Slow renal excretion</p>
                        <p><strong>S/E:</strong></p>
                        <p>Immediate:</p>
                        <ul>
                            <li>Fatigue, vomiting</li>
                            <li>Seizures, shock, death</li>
                        </ul>
                        <p>Later reactions:</p>
                        <ul>
                            <li>Neuropathy, paresthesias.</li>
                            <li>Renal damage</li>
                            <li>Hematologic effects - hemolysis, agranulocytosis</li>
                        </ul>
                        <p><strong>Uses:</strong> Early (hemolymphatic) stages of African trypanosomiasis</p>
                        <p><strong>Dose:</strong> 200 mg IV stat then 20mg/kg IV on days 1, 3, 7, 14, & 21.</p>

                        <h3 class="subsection-heading">2. PENTAMIDINE</h3>
                        <p><strong>Mxn:</strong> thought to interfere with nuclear metabolism</p>
                        <p><strong>Adm:</strong> parenteral</p>
                        <p><strong>Distribution:</strong> sequestered and accumulates in tissues but NOT CNS, followed by slow release back into circulation</p>
                        <p><strong>Elimination:</strong> $t_{1/2}$ - long</p>
                        <p><strong>S/E (highly toxic, and common):</strong></p>
                        <ul>
                            <li>Hypotension, tachycardia, dizziness, dyspnea due to rapid IV infusion.</li>
                            <li>Pancreatic toxicity - (hypoglycemia later followed by hyperglycemia)</li>
                            <li>Renal damage (reversible) & Liver damage</li>
                            <li>Metallic taste</li>
                        </ul>
                        <p><strong>Uses:</strong></p>
                        <ul>
                            <li>Alternative (to Suramin) in early (hemolymphatic stages) African trypanosomiasis</li>
                            <li>Visceral leishmaniasis - Alternative to sodium stibogluconate</li>
                            <li>Pneumocystis jiroveci infection: Alternative to Cotrimoxazole</li>
                        </ul>

                        <h3 class="subsection-heading">3. MELARSOPROL</h3>
                        <p><strong>Adm:</strong> parenteral</p>
                        <p><strong>Distribution:</strong> slow accumulation in the CNS</p>
                        <p><strong>Elimination:</strong> rapid metabolism, urinary & fecal excretion</p>
                        <p><strong>S/E (very toxic):</strong></p>
                        <ul>
                            <li>Fever, arthalgia, vomiting, Hypertension</li>
                            <li>Reactive encephalopathy (reaction to byproducts of trypanosome death) - leads to cerebral edema, seizures, coma, death</li>
                            <li>Renal damage, Cardiac toxicities, Hypersensitivity</li>
                        </ul>
                        <p><strong>Uses:</strong> Advanced trypanosomiasis (CNS disease) 1st line drug</p>

                        <h3 class="subsection-heading">4. EFLORNITHINE</h3>
                        <p><strong>Adm:</strong> oral & parenteral with adequate absorption.</p>
                        <p><strong>Distribution:</strong> achieves effective CNS penetration</p>
                        <p><strong>Elimination:</strong> renal excretion</p>
                        <p><strong>S/E (most are reversible & less toxic than melarsoprol):</strong></p>
                        <ul>
                            <li>GIT disturbance</li>
                            <li>Hematologic abnormalities - anemia, leucopenia, thrombocytopenia</li>
                            <li>Seizures, Hearing loss, Teratogenic risk</li>
                        </ul>
                        <p><strong>Uses:</strong> Advanced (CNS) African trypanosomiasis</p>
                        <p><strong>Dose:</strong> 100mg/kg IV QID for 7-14 days</p>

                        <h3 class="subsection-heading">5. NIFURTIMOX</h3>
                        <p><strong>Adm:</strong> oral & good absorption.</p>
                        <p><strong>S/E:</strong></p>
                        <ul>
                            <li>GIT irritation</li>
                            <li>Hypersensitivity reactions</li>
                            <li>Neuropathies (seizures, vertigo, fever, restlessness, insomnia)</li>
                            <li>Myalgia, arthralgia</li>
                        </ul>
                        <p><strong>Uses:</strong> Acute Chaga's disease (early stages)- not effective in chronic disease.</p>
                    </div>
                </section>
                <!-- END: trypanosomiasis-treatment -->

                <!-- START: leishmaniasis-treatment -->
                <section id="leishmaniasis-treatment" class="content-section" aria-labelledby="section-heading-leishmaniasis">
                    <h2 id="section-heading-leishmaniasis" class="section-heading">
                         <span class="heading-icon">ü¶ü</span>
                        <span class="heading-text">TREATMENT OF LEISHMANIASIS: cutaneous, mucocutaneous, visceral</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">1. SODIUM STIBOGLUCONATE</h3>
                        <p><strong>Adm:</strong> parenteral (not absorbed orally)</p>
                        <p><strong>Distribution:</strong> some sequestration into tissues.</p>
                        <p><strong>Elimination:</strong> renal excretion</p>
                        <p><strong>S/E (toxicity increases with duration of therapy):</strong></p>
                        <ul>
                            <li>Pain at injection site</li>
                            <li>GIT disturbance</li>
                            <li>Fever, headache, myalgias, arthralgias</li>
                            <li>Cardiac conduction defects -arrhythmias</li>
                            <li>Hepatic and renal damage</li>
                            <li>Hemolytic anemia</li>
                        </ul>
                        <p><strong>Uses:</strong></p>
                        <ul>
                            <li>Cutaneous & mucocutaneous leishmaniasis (1st line)</li>
                            <li>Visceral leishmaniasis (1st line)</li>
                        </ul>
                        <p><strong>Dose:</strong> 20mg/kg/d IV or IM (OD)for 20 days (cutaneous leishmaniasis) and 28 days (visceral and mucocutaneous disease).</p>
                        <p>Other anti-leishmania agents that can be combined with sodium stibogluconate:</p>
                        <ol start="2">
                            <li>Pentamidine</li>
                            <li>Amphotericin B</li>
                        </ol>
                    </div>
                </section>
                <!-- END: leishmaniasis-treatment -->

                <!-- START: anti-helminthics -->
                <section id="anti-helminthics" class="content-section" aria-labelledby="section-heading-antihelminthics">
                    <h2 id="section-heading-antihelminthics" class="section-heading">
                         <span class="heading-icon">ü™±</span>
                        <span class="heading-text">ANTI-HELMINTHICS</span>
                    </h2>
                    <div class="content-card">
                        <p>Helminths are large, multicellular organisms that are generally visible to the naked eye in their adult stages</p>
                        <p>Anthelmintics or antihelminthics are drugs that expel parasitic worms (helminths) from the body, by either stunning or killing them</p>
                        <p>This includes both flat worms, e.g., flukes and tapeworms and round worms, i.e., nematodes.</p>

                        <h3 class="subsection-heading">1. BENZIMIDAZOLES</h3>
                        <p>E.g. Albendazole, mebendazole, thiabendazole</p>
                        <p><strong>Spectrum:</strong> broad</p>
                        <p><strong>Adm:</strong> oral with minimal absorption.</p>
                        <p><strong>Distribution:</strong> plasma concentration of albendazole is $\times 100$ that of mebendazole</p>
                        <p><strong>Elimination:</strong> rapid metabolism, biliary & renal excretion of products</p>
                        <p><strong>S/E:</strong> GIT irritation, Rash. Teratogenic and embryotoxic risk (best avoided in pregnancy). More toxic effects with Thiabendazole (CNS disturbance, Steven Johnsons syndrome, dizziness, GIT upset)</p>
                        <p><strong>Uses:</strong></p>
                        <ul>
                            <li><strong>Mebendazole:</strong> Hookworm, roundworm, pinworm & whipworms</li>
                            <li><strong>Thiabendazole:</strong> strongyloidiasis, cutaneous larva migrans</li>
                            <li><strong>Albendazole:</strong>
                                <ol>
                                    <li>Intestinal Nematode infestation - Hook, Round, Whip, Pinworms (enterobiasis), Strongyloidiasis</li>
                                    <li>DOC in Hydatid disease- (usually in combination with praziquantel)</li>
                                    <li>DOC in Neurocysticercosis (combined with a corticosteroid)</li>
                                    <li>Cutaneous larva migrans.</li>
                                </ol>
                            </li>
                        </ul>

                        <h3 class="subsection-heading">2. LEVAMISOLE</h3>
                        <p><strong>Administration:</strong> oral</p>
                        <p><strong>Absorption:</strong> rapid</p>
                        <p><strong>Distribution:</strong> wide including CSF</p>
                        <p><strong>Elimination:</strong> metabolized, renal excretion.</p>
                        <p><strong>S/E:</strong> GIT irritation</p>
                        <p><strong>Uses:</strong> Round worms</p>

                        <h3 class="subsection-heading">3. PYRANTEL PAMOATE</h3>
                        <p><strong>Administration:</strong> oral</p>
                        <p><strong>Absorption:</strong> poor.</p>
                        <p><strong>S/E:</strong> GIT irritation (nausea, vomiting, diarrhea). Mild CNS disturbance -headache, insomnia, drowsiness</p>
                        <p><strong>Uses:</strong> Hookworm, roundworm, pinworms</p>

                        <h3 class="subsection-heading">4. PIPERAZINE</h3>
                        <p><strong>Administration:</strong> oral & moderately absorbed.</p>
                        <p><strong>Elimination:</strong> renal excretion</p>
                        <p><strong>S/E:</strong> GIT disturbance. Allergic reactions: Urticaria, fever, bronchospasm. Mild neurotoxicity - dizziness, somnolence, paresthesia, vertigo, inco-ordination, visual disturbance.</p>
                        <p><strong>C/I:</strong> Persons with History of neurological disease. Persons with impaired hepatic or renal function. Do not co-adminster with phenothiazines e.g. chlorpromazine. Avoid in pregnancy</p>
                        <p><strong>Uses:</strong> Roundworm and pinworms. Treatment of filariasis</p>

                        <h3 class="subsection-heading">5. IVERMECTIN</h3>
                        <p>Microfilaricidal</p>
                        <p><strong>Administration:</strong> oral (on empty stomach)</p>
                        <p><strong>Absorption:</strong> rapid</p>
                        <p><strong>Distribution:</strong> wide, slowly into eyes (but not meninges)</p>
                        <p><strong>Elimination:</strong> metabolism, biliary excretion</p>
                        <p><strong>USES:</strong></p>
                        <ol>
                            <li>Onchocerciasis</li>
                            <li>Strongyloidiasis</li>
                            <li>Elephantiasis ($2^{\text{nd}}$ line, or combined with diethlycarbazine)</li>
                            <li>Others: Cutaneous larva migrans & Scabies</li>
                        </ol>
                        <p><strong>S/E (Ivermectin):</strong> Mazotti reaction: hypotension, tachycardia, lymphangitis, lymphadenopathy, peripheral edema, dizziness, somnolence, rash, pruritus, myalgia, arthralgia. Bronchospasm, corneal opacities, eyelid edema, conjunctivitis, keratitis, optic neuritis.</p>
                        <p><strong>Caution & C/I:</strong> Avoid simultaneous use with barbiturates, benzodiazepines, valproic acid. Avoid in pregnancy, breastfeeding and children <5yrs. Avoid in those with impaired Blood Brain Barrier e.g meningitis</p>

                        <h3 class="subsection-heading">6. DIETHYLCARBAZINE</h3>
                        <p>Micro and macrofilaricide</p>
                        <p><strong>Administration:</strong> per oral & rapidly absorbed.</p>
                        <p><strong>Distribution:</strong> into all tissues except fat tissue.</p>
                        <p><strong>Elimination:</strong> Mainly renal excretion.</p>
                        <p><strong>S/E:</strong> GIT irritation - nausea, vomiting, anorexia. Headache, dizziness, malaise, sleepiness</p>
                        <p><strong>Uses:</strong></p>
                        <ol>
                            <li>DOC in treatment & prophylaxis of W. bancrofti (elephatiasis), B. malayi, Loa loa (loiasis)</li>
                            <li>Onchocerciasis</li>
                            <li>Mass treatment for W. bancrofti to reduce transmission</li>
                        </ol>
                        <p>Take caution in persons with: Hypertension, Renal disease.</p>

                        <h3 class="subsection-heading">7. NICLOSAMIDE</h3>
                        <p><strong>Adm:</strong> oral (chew, on empty stomach - best taken 2 hrs before breakfast)</p>
                        <p><strong>Absorption:</strong> minimal</p>
                        <p><strong>S/E:</strong> GIT effects, Headache, vertigo. Rash, urticaria, pruritus.</p>
                        <p><strong>Caution:</strong> Avoid alcohol. Avoid in pregnancy and children below 2 yrs.</p>
                        <p><strong>Uses:</strong> DOC in beef, pork and fish tapeworms. Dwarf tapeworm (alternative to praziquantel). Alternative in intestinal flukes (e.g. Fasciolopsis buski)</p>

                        <h3 class="subsection-heading">8. PRAZIQUANTEL</h3>
                        <p><strong>Adm:</strong> Oral &rapid absorption especially with carbohydrate meal</p>
                        <p><strong>Distribution:</strong> wide including CSF, breast milk.</p>
                        <p><strong>Elimination:</strong> renal & biliary excretion</p>
                        <p><strong>S/E:</strong> Fever, headache, dizziness, drowsiness, lassitude. GIT effects, Rash, pruritus, urticaria. Mild liver damage. Reaction to dying parasite. Mental changes, seizures, increased CSF fluid, arachnoiditis, hyperthermia.</p>
                        <p><strong>C/I (Praziquantel):</strong> Ocular cysticercosis - parasite degeneration leads to irreparable damage. Avoid in pregnancy. Stop breastfeeding for 3 days after treatment.</p>
                        <p><strong>Uses:</strong></p>
                        <ol>
                            <li>Schistosomiasis - DOC for all forms</li>
                            <li>Hymenolepsis nana- Dwarf Tapeworm - DOC</li>
                            <li>Taeniasis</li>
                            <li>Neurocysticercosis - alternative to albendazole.</li>
                            <li>Hydatid disease - added to albendazole.</li>
                        </ol>

                        <h3 class="subsection-heading">9. METRIFONATE</h3>
                        <p><strong>Administration:</strong> oral and ready absorbed.</p>
                        <p><strong>Distribution:</strong> well, wide</p>
                        <p><strong>S/E:</strong> Bronchospasm, diarrhea, abdominal spasms. Dizziness, vertigo. Sweating</p>
                        <p><strong>C/I:</strong> Avoid use of muscle relaxants, or in persons recently exposed to organophosphates. Avoid in pregnancy</p>
                        <p><strong>USE:</strong> Schistosoma haematobium.</p>

                        <h3 class="subsection-heading">10. OXAMNIQUINE</h3>
                        <p>Acts only on S. mansoni</p>
                        <p><strong>Adm:</strong> oral, taken with food & readily absorbed.</p>
                        <p><strong>Elimination:</strong> metabolized followed by renal excretion</p>
                        <p><strong>S/E:</strong> Fever, headache, dizziness, drowsiness. GIT effects, Urticaria, pruritus. Orange discoloration of urine</p>
                        <p><strong>Uncommon S/E:</strong> Seizures, insomnia, amnesia, behavioral change, hallucinations. Microhematuria, proteinuria</p>
                        <p><strong>Caution (Oxamniquine):</strong> In patients with epilepsy</p>
                        <p><strong>C/I:</strong> in pregnancy</p>
                        <p><strong>USES:</strong> S. mansoni infection.</p>
                    </div>
                </section>
                <!-- END: anti-helminthics -->

                <!-- START: anti-protozoal-agents -->
                <section id="anti-protozoal-agents" class="content-section" aria-labelledby="section-heading-antiprotozoal">
                    <h2 id="section-heading-antiprotozoal" class="section-heading">
                         <span class="heading-icon">ü¶†</span>
                        <span class="heading-text">ANTI-PROTOZOAL AGENTS</span>
                    </h2>
                    <div class="content-card">
                        <p>Protozoa are microscopic, one-celled organisms that can be free-living or parasitic in nature.</p>
                        <p>Transmission of protozoa that live in a human's intestine to another human typically occurs through a fecal-oral route (for example, contaminated food or water or person-toperson contact).</p>
                        <p>Protozoa that live in the blood or tissue of humans are transmitted to other humans by an arthropod vector (for example, through the bite of a mosquito or sand fly).</p>

                        <h3 class="subsection-heading">AMOEBIASIS (E. histolytica)</h3>
                        <ul>
                            <li>Trophozoites and cysts are involved.</li>
                            <li>Trophozoites can invade colon epithelium causing ulceration; can spread to liver.</li>
                            <li>Trophozoites can simply live on gut bacteria thus broadspectrum antiobiotic can eradicate them.</li>
                        </ul>
                        <p>Range of illness/symptoms:</p>
                        <ul>
                            <li>Asymptomatic carrier</li>
                            <li>Mild diarrhea</li>
                            <li>Fulminant dysentery</li>
                        </ul>

                        <h4 class="subsubsection-heading">1. Metronidazole & Tinidazole</h4>
                        <ul>
                            <li>Metronidazole is a nitroimidazole antibiotic medication used particularly for anaerobic bacteria and protozoa.</li>
                            <li>Metronidazole is an antibiotic, amebicide, and antiprotozoal.</li>
                            <li>Tinidazole is a synthetic antiprotozoal and antibacterial agent.</li>
                        </ul>
                        <p><strong>Mxn:</strong> the drug is reduced to reactive products toxic to DNA & proteins- producing cidal activity.</p>
                        <p><strong>Administration:</strong> oral, parenteral</p>
                        <p><strong>Absorption:</strong> complete & rapid</p>
                        <p><strong>Distribution:</strong> well into all tissues (including saliva, breast milk)</p>
                        <p><strong>Elimination:</strong> Metabolized in liver then excretion by renal route.</p>
                        <p><strong>S/E (Metronidazole & Tinidazole):</strong></p>
                        <ul>
                            <li>Metallic taste</li>
                            <li>GIT irritation -hence take with food</li>
                            <li>Disulfiram-like reaction with alcohol</li>
                            <li>Neurotoxic - (especially with parenteral administration.)</li>
                            <li>Monoliasis (oral candidiasis)</li>
                            <li>Pancreatitis</li>
                        </ul>
                        <p>best avoided in pregnancy</p>
                        <p><strong>D/I (Metronidazole):</strong> Potentiates effect of oral anticoagulants. Potentiates toxicity of lithium</p>
                        <p><strong>Uses (Metronidazole):</strong></p>
                        <ol>
                            <li>DOC for all extra - intestinal amebiasis (add a luminally active agent for eradication) = 800mg TDS*5/7</li>
                            <li>DOC for giardiasis = 2g daily*3/7</li>
                            <li>DOC for trichomoniasis = 400mg BD*1/52</li>
                            <li>Anaerobic bacteria-infections of the vagina, stomach, skin, joints, and respiratory tract = 400mg TDS.</li>
                        </ol>

                        <h4 class="subsubsection-heading">2. Diloxanide furoate (Dyrade-M)</h4>
                        <p><strong>Mxn:</strong> unknown</p>
                        <p><strong>Uses:</strong> Luminal amoebiasis. Treatment of asymptomatic carriers or used along with tissue amebicide to eradicate infection</p>
                        <p><strong>Administration:</strong> oral</p>
                        <p><strong>Absorption:</strong> most of diloxanide is absorbed (90%) - what is left (10%) is still effective</p>
                        <p><strong>Elimination:</strong> metabolized in liver then undergoes renal excretion</p>
                        <p><strong>S/E (Diloxanide furoate):</strong> Flatulence. Dry mouth. Nausea, abdominal cramps. Allergic reaction</p>
                        <p><strong>C/I:</strong> pregnancy and young children (<2yrs)</p>

                        <h4 class="subsubsection-heading">3. PARAMOMYCIN (an aminoglycoside)</h4>
                        <p><strong>Uses:</strong> Luminal amebicide. Tapeworm infestation (not DOC). Cryptosporidiosis (as an alternative)</p>
                        <p><strong>Adm:</strong> oral & absorption is insignificant</p>
                        <p><strong>S/E:</strong> GIT irritation, diarrhea</p>
                        <p><strong>Caution:</strong> Persons with GIT ulcers. Persons with renal dysfunction.</p>

                        <h4 class="subsubsection-heading">4. IODOQUINOL</h4>
                        <p><strong>Uses:</strong> Luminal amebicide</p>
                        <p><strong>Adm:</strong> oral with poor absorption</p>
                        <p><strong>Elimination:</strong> metabolized by liver & renal excretion</p>
                        <p><strong>S/E:</strong> GIT distress, Headache, Allergic reaction(skin)</p>
                        <p><strong>D/I:</strong> Increases protein binding of iodine, decreasing serum iodine</p>
                        <p><strong>C/I:</strong> In persons intolerant to iodine</p>
                        <p><strong>Caution in:</strong> thyroid disease, renal and hepatic impairment & optic neuropathy</p>

                        <h4 class="subsubsection-heading">5. CHLOROQUINE</h4>
                        <p><strong>Uses:</strong> Extra-intestinal amebiasis (along with metronidazole and diloxanide). Sensitive plasmodium parasites (malaria)</p>

                        <h4 class="subsubsection-heading">6. EMETINE & DIHYDROEMETINE (very effective)</h4>
                        <p><strong>Adm:</strong> parenteral -S.C or I.M-(NEVER IV)</p>
                        <p><strong>Distribution:</strong> the drug is concentrated in the liver</p>
                        <p><strong>Elimination:</strong> Slow metabolism in liver & excretion by kidneys.</p>
                        <p><strong>S/E:</strong> Increase with dosage and duration (NEVER use drug for > 10 days). Pain at site of injection, sterile abscess. GIT distress. Muscle weakness, ECG changes, dizziness, rashes</p>
                        <p><strong>Serious S/E:</strong> Cardiotoxic -can cause arrhythmias, hypotension, Congestive cardiac failure.</p>
                        <p><strong>C/I:</strong> Heart disease, Renal failure, Children <12yrs, Pregnancy</p>
                        <p><strong>Uses:</strong> Systemic amebiasis (last alternative, or in seriously ill persons). Fasciola hepatica (as an alternative)</p>

                        <h3 class="subsection-heading">OTHER INTESTINAL PROTOZOAS</h3>
                        <p><strong>Giardiasis</strong> - Metronidazole, Mepacrine</p>
                        <p><strong>Trichomoniasis</strong> - Metronidazole, Tinidazole</p>
                        <p>Less common intestinal protozoa:</p>
                        <ul>
                            <li><strong>Cryptosporidiosis</strong> (usually associated with immunocompromised states) - Paramomycin, Azithromycin</li>
                            <li><strong>Balantidium coli</strong> - Tetracycline, Metronidazole</li>
                            <li><strong>Isospora belli</strong> - Co-trimoxazole, Pyrimethamine</li>
                        </ul>
                    </div>
                </section>
                <!-- END: anti-protozoal-agents -->

                <!-- START: antimalarial-drugs -->
                <section id="antimalarial-drugs" class="content-section" aria-labelledby="section-heading-antimalarials">
                    <h2 id="section-heading-antimalarials" class="section-heading">
                         <span class="heading-icon">ü¶ü</span>
                        <span class="heading-text">ANTIMALARIAL DRUGS</span>
                    </h2>
                    <div class="content-card">
                        <figure>
                            <img src="../assets/images/2025_06_04_448780967d4f74d330c7g-06-1.jpg" alt="Diagram illustrating the life cycle of the malaria parasite (Plasmodium) showing stages in mosquito and human host, including liver and blood stages." class="content-image">
                            <figcaption>Life cycle of the malaria parasite.</figcaption>
                        </figure>

                        <h3 class="subsection-heading">1. ARTEMISININ and its derivatives</h3>
                        <ul>
                            <li>Artemisinin - Limited to oral use</li>
                            <li>Artesunate - oral, IV, IM, rectal</li>
                            <li>Artemether - oral, IM, rectal</li>
                            <li>Combined with drugs such as mefloquine, lumefantrine (Coartem), amodiaquine, piperaquine (Duo-Cotecxin), and pyronaridine (Pyramax). =Artemisinin-based Combination Therapy (ACT)</li>
                        </ul>
                        <p><strong>Mxn:</strong> Fast acting blood schizonticide on all species, kill the parasites-not well known</p>
                        <p><strong>Uses:</strong> Standard for RX of uncomplicated P. falciparum</p>
                        <p><strong>S/E (fairly well tolerated):</strong> GIT disturbance (nausea, vomiting, diarrhea). Irreversible neurotoxicity w/ high doses. Avoid in pregnancy</p>
                        <p>NB: WHO discourages monotherapy</p>
                        <figure>
                            <img src="../assets/images/2025_06_04_448780967d4f74d330c7g-09-1.jpg" alt="Diagram showing sites of action of antimalarial drugs within the malaria parasite life cycle (sporozoites, liver schizonts, merozoites, blood schizonts, gametocytes)." class="content-image">
                            <figcaption>Sites of action of antimalarial drugs.</figcaption>
                        </figure>

                        <h3 class="subsection-heading">2. Sulfonamide-pyrimethamine</h3>
                        <p><strong>Pyrimethamine:</strong></p>
                        <ul>
                            <li>Pyrimethamine interferes with tetrahydrofolic acid synthesis from folic acid - folate needed to synthesize DNA</li>
                            <li>Acts slowly against all erythrocytic stage of all species of plasmodium.</li>
                        </ul>
                        <p><strong>Adm:</strong> oral</p>
                        <p><strong>Elimination:</strong> long $t_{1/2}$ -(allows once a week dosing)</p>
                        <p><strong>S/E:</strong> GIT irritation. Rashes, itching. Teratogenic in animals (use if benefits outweigh risk in pregnancy). Always supplement folic acid if antifolates are used in pregnancy</p>
                        <p><strong>Uses (Sulfonamide-pyrimethamine):</strong></p>
                        <ul>
                            <li>Malaria prophylaxis e.g. pregnancy</li>
                            <li>Toxoplasmosis - a parasitic disease caused by the protozoan Toxoplasma gondii (combined with sulfadiazine or clindamycin and folic acid)</li>
                        </ul>
                        <p>Examples:</p>
                        <ul>
                            <li>FANSIDAR = SULPHADOXINE + PYRIMETHAMINE</li>
                            <li>METAKELFIN = SULPHALENE + PYRIMETHAMINE</li>
                        </ul>

                        <h3 class="subsection-heading">3. PROGUANIL</h3>
                        <p>A slowly acting blood schizonticide against all 4 forms of plasmodium</p>
                        <p><strong>Adm:</strong> oral & adequately absorbed.</p>
                        <p><strong>Elimination:</strong> $t_{1/2}$ - long (once daily dosing)</p>
                        <p><strong>S/E:</strong> GIT irritation, Skin rash, Mouth ulcers & Alopecia</p>
                        <p><strong>Uses:</strong> Prophylaxis of malaria - (alternative to mefloquine)</p>
                        <p><strong>Dose:</strong> 2 tabs daily.</p>

                        <h3 class="subsection-heading">4. QUININE & QUINIDINE</h3>
                        <ul>
                            <li>Quinine is a natural white crystalline alkaloid having antipyretic (fever-reducing), antimalarial, analgesic (painkilling), and anti-inflammatory properties and a bitter taste</li>
                            <li>Quinidine is an antimalarial schizonticide and an antiarrhythmic agent ; it is the isomer of quinine</li>
                        </ul>
                        <p><strong>MOA:</strong> not well known, but rapid blood schizonticide against all 4 species.</p>
                        <p><strong>Adm:</strong> oral, parenteral</p>
                        <p><strong>Abs:</strong> rapid, impaired by $\text{Al}^{3+}$ containing antacids</p>
                        <p><strong>Distribution:</strong> wide & with extensive protein-binding hence a loading dose is required.</p>
                        <p><strong>Elimination:</strong> Liver metabolism, renal excretion (NB. Monitor in renal impairment)</p>
                        <figure>
                             <img src="../assets/images/2025_06_04_448780967d4f74d330c7g-14-1.jpg" alt="Chemical structure of Quinine." class="content-image">
                             <figcaption>Chemical structure of Quinine.</figcaption>
                        </figure>
                        <p><strong>S/E (Quinine & Quinidine):</strong></p>
                        <ol>
                            <li><strong>Cinchonism</strong> - a combination of -Tinnitus, visual disturbance, dizziness, headache, nausea</li>
                        </ol>
                        <p><strong>Serious S/E:</strong></p>
                        <ol start="2">
                            <li>Audio-visual disturbance</li>
                            <li>Hypersensitivity reactions</li>
                            <li>Hypoglycemia (stimulates insulin release, felt most in pregnancy)</li>
                            <li>GIT irritation</li>
                            <li>Hematological abnormalities - hemolysis, leukopenia, agranulocytosis, thrombocytopenia</li>
                            <li>Thrombophlebitis at site of infusion</li>
                            <li>Mild uterine contractions (esp. 3rd trimester)</li>
                            <li>Hypotension - with rapid infusion</li>
                        </ol>
                        <p><strong>Precautions/avoid in (Quinine):</strong> Severe cinchonism (discontinue therapy). Auditory or visual problems. Presence of myasthenia gravis. Cardiac abnormalities. Patients who have recently received mefloquine</p>
                        <p><strong>D/I:</strong> Mefloquine (increases quinine toxicity) - do not co-administer. Quinine raises the plasma conc. of Warfarin and Digoxin</p>
                        <p><strong>Uses (Quinine):</strong></p>
                        <ol>
                            <li>Severe falciparum malaria (DOC, parenteral)</li>
                            <li>Babesiosis (Babesia microti) - Babesiosis is a malaria-like parasitic disease caused by infection with Babesia- DOC in combination with clindamycin</li>
                            <li>Nocturnal leg cramps</li>
                        </ol>
                        <p><strong>Dose:</strong> P.O = 600mg TDS * 1/52. IV infusion: loading with 20mg/kg (max. 1.4g) then 10mg/kg (max. 700mg) TDS over 4 hours. NB: When patient can swallow, switch to oral</p>

                        <h3 class="subsection-heading">5. MEFLOQUINE</h3>
                        <p>Strong blood schizonticide</p>
                        <p><strong>Adm:</strong> oral (produces severe local irritation with parenteral use)</p>
                        <p><strong>Absorption:</strong> good but slow</p>
                        <p><strong>Distribution:</strong> extensively in tissues</p>
                        <p><strong>Elimination:</strong> $t_{1/2}$ - long. Some metabolism, Biliary excretion mainly.</p>
                        <p><strong>S/E:</strong> GIT irritation, Sleep disorders. Behavioral (Neuropsychiatric) disturbance. Hepatic damage, arrhytmias. Leukopenia and thrombocytopenia</p>
                        <p><strong>C/I (Mefloquine):</strong> - in the presence or History of:</p>
                        <ol>
                            <li>Cardiac conduction defects</li>
                            <li>Epilepsy</li>
                            <li>Neuropsychiatric disorders</li>
                            <li>Hypersensitivity (to related drugs) e.g. Quinine, quinidine or halofantrine (do not coadminister)</li>
                        </ol>
                        <p><strong>Uses:</strong> Chemoprophylaxis = 1 tab (250mg) weekly. NB.co-administer with primaquine for radical cure of P. vivax & ovale)</p>

                        <h3 class="subsection-heading">6. HALOFANTRINE</h3>
                        <p>Rapid blood schizonticide against all 4 species</p>
                        <p><strong>Administration:</strong> oral</p>
                        <p><strong>Absorption:</strong> variable, enhanced with meals (especialy fatty foods)- but take on empty stomach to avoid high plasma conc. associated with toxicities</p>
                        <p><strong>S/E:</strong> GIT irritation - Headache, cough. Pruritus, rash - Mild hepatic damage. Cardiac conduction defects - arrhythmias, death. Embryotoxic in animals</p>
                        <p><strong>C/I (Halofantrine):</strong> Persons with cardiac conduction defects. Persons recently on mefloquine. Pregnancy</p>
                        <p><strong>Uses:</strong> Treatment of falciparum malaria (NOT for chemoprophylaxis)</p>
                        <p><strong>Dose:</strong> >40kg = 500mg TDS- QID (max 6 tabs). <40kg = 8mg/kg QID (max 24mg/kg).</p>

                        <h3 class="subsection-heading">8. PRIMAQUINE (Note: Numbering from PDF, likely should be 7)</h3>
                        <p>The only drug against hypnozoites (dormant state in liver. It is also gametocidal</p>
                        <p><strong>Adm:</strong> oral (NEVER give parenteral -lead to severe hypotension)</p>
                        <p><strong>Abs:</strong> adequate</p>
                        <p><strong>S/E:</strong> GIT distress - take w/ food. Hemolysis and methemoglobinemia esp in G6PDH deficiency</p>
                        <p><strong>Serious S/E:</strong> Hematological abnormalities - leucopenia, agranulocytosis. Cardiac arrhythmias</p>
                        <p><strong>C/I (Primaquine):</strong> Those at risk of granulocytopenia, methemoglobinemia (Methemoglobin is an oxidized form of hemoglobin that has a decreased affinity for oxygen). In pregnancy</p>
                        <p><strong>Uses:</strong> Radical cure of P. vivax & ovale infections (add a schizonticide too). Terminal prophylaxis (after end of travel) to eradicate any liver forms. Alternative for mild Pneumocystis jiroveci infection (along w/ clindamycin)</p>
                        <p><strong>Dose:</strong> 15 mg OD (PO) for 2-3 weeks.</p>

                        <h3 class="subsection-heading">9. AMODIAQUINE (Camoquin, Flavoquine)</h3>
                        <p>The mode of action of amodiaquine has not yet been determined.</p>
                        <p><strong>Adm:</strong> oral</p>
                        <p><strong>S/E:</strong> Agranulocytosis, hepatotoxic, peripheral neuropathy, visual disturbances. Aminoquinolines depress cardiac muscle, impair cardiac conductivity, and produce vasodilatation with resultant hypotension.</p>
                        <p><strong>Uses:</strong> Sensitive strains of malaria (don't use for prophylaxis due to its S/E)</p>
                        <p><strong>Dose:</strong> 600 mg (PO) OD X 3/7</p>

                        <h3 class="subsection-heading">10. Antibacterials used as antimalarials</h3>
                        <p>E.g.Tetracycline, doxycycline, clindamycin</p>
                        <p>Are SLOW schizonticides- hence never use alone for treatment.</p>
                        <p><strong>Uses:</strong> Treatment of falciparum malaria in conjunction with other drugs e.g. quinine. Chemoprophylaxis of malaria (Doxycycline).</p>

                        <h3 class="subsection-heading">WHO guidelines</h3>
                        <ul>
                            <li>Artemisinin-based combination therapies (ACTs) are the recommended treatments for uncomplicated P. falciparum malaria.</li>
                            <li>Severe malaria is a medical emergency.</li>
                            <li>For adults, artesunate IV or IM: OR artemether or quinine is an acceptable alternative if parenteral artesunate is not available.</li>
                            <li>Give parenteral antimalarials in the treatment of severe malaria for a minimum of 24h</li>
                        </ul>
                    </div>
                </section>
                <!-- END: antimalarial-drugs -->

            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="pharmacology-chemotherapeutic-agents-antimycobacterials-antifungals-antivirals.html" class="nav-button">
                        <span class="nav-icon">‚Üê</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 36%;"></div> <!-- Set percentage dynamically -->
                        </div>
                       <span class="progress-text">Lecture 4 of 11</span> <!-- Update text -->
                    </div>
                    <a href="pharmacology-cancer-chemotherapy.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">‚Üí</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script> <!-- Basic JS for disabled links etc. -->
</body>
</html>